Design and fabrication of effective biomimetic vasculatures constitutes a relevant and yet unsolved challenge, lying at the heart of tissue repair and regeneration strategies. Even if cell growth is achieved in 3D tissue scaffolds or advanced implants, tissue viability inevitably requires vascularization, as diffusion can only transport nutrients and eliminate debris within a few hundred microns. This engineered vasculature may need to mimic the intricate branching geometry of native microvasculature, referred to herein as vascular complexity, to efficiently deliver blood and recreate critical interactions between the vascular and perivascular cells as well as parenchymal tissues. This review first describes the importance of vascular compl...
A major challenge in engineering scalable three-dimensional tissues is the generation of a functiona...
Rapid progress in tissue engineering research in past decades has opened up vast possibilities to ta...
The increasing gap between clinical demand for tissue or organ transplants and the availability of d...
Design and fabrication of effective biomimetic vasculatures constitutes a relevant and yet unsolved ...
Microphysiological systems (MPSs) (i.e., tissue or organ chips) exploit microfluidics and 3D cell cu...
Recent advances in medicine and healthcare allow people to live longer, increasing the need for the ...
\u3cp\u3eThe development of Vasculature-on-Chip has progressed rapidly over the last decade and rece...
Organ-on-a-Chip (OOC) devices have seen major advances in the last years with respect to biological ...
Functional and perfusable vascular network formation is critical to ensure the long-term survival an...
Abstract Vascularization of 3D models represents a major challenge of tissue engineering and a key p...
Numerous microfabrication approaches have been developed to recapitulate morphologically and functio...
From the inception of tissue engineering, tissue vascularization has been one of the greatest challe...
In this work, a novel strategy was developed to fabricate prevascularized cell-layer blood vessels i...
International audienceSince the emergence of regenerative medicine and tissue engineering more than ...
The ability to manufacture human tissues that replicate the spatial, mechano-chemical, and temporal ...
A major challenge in engineering scalable three-dimensional tissues is the generation of a functiona...
Rapid progress in tissue engineering research in past decades has opened up vast possibilities to ta...
The increasing gap between clinical demand for tissue or organ transplants and the availability of d...
Design and fabrication of effective biomimetic vasculatures constitutes a relevant and yet unsolved ...
Microphysiological systems (MPSs) (i.e., tissue or organ chips) exploit microfluidics and 3D cell cu...
Recent advances in medicine and healthcare allow people to live longer, increasing the need for the ...
\u3cp\u3eThe development of Vasculature-on-Chip has progressed rapidly over the last decade and rece...
Organ-on-a-Chip (OOC) devices have seen major advances in the last years with respect to biological ...
Functional and perfusable vascular network formation is critical to ensure the long-term survival an...
Abstract Vascularization of 3D models represents a major challenge of tissue engineering and a key p...
Numerous microfabrication approaches have been developed to recapitulate morphologically and functio...
From the inception of tissue engineering, tissue vascularization has been one of the greatest challe...
In this work, a novel strategy was developed to fabricate prevascularized cell-layer blood vessels i...
International audienceSince the emergence of regenerative medicine and tissue engineering more than ...
The ability to manufacture human tissues that replicate the spatial, mechano-chemical, and temporal ...
A major challenge in engineering scalable three-dimensional tissues is the generation of a functiona...
Rapid progress in tissue engineering research in past decades has opened up vast possibilities to ta...
The increasing gap between clinical demand for tissue or organ transplants and the availability of d...